Startups channel feed – Endpoints News

Startups channel feed

Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

8 months ago

Septerna outlines $157M IPO after entering the clinic with GPCR pipeline

8 months ago

Former Karuna crew quickly assembles $225M for next neuro bet at Seaport

8 months ago

Secretive Treeline Biosciences discloses $421M financing in filing

8 months ago

RNA gene therapy startup Shape hunts for new CEO as Series C awaits

8 months ago

Hospitals gush about new AI note-taking tools. It may leave the human medical scribes who originated the roles behind

8 months ago

Life sciences investor KdT Ventures raises $100M fund to back new startups

8 months ago

Seeking to treat obesity drug side effect, Neurogastrx releases data on drug for GLP-1-associated nausea, vomiting

8 months ago

Tolerance Bio emerges from stealth with $17.2M to advance therapies developed from the thymus

8 months ago

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

8 months ago

VC firm targets $35M second fund to back startups led by scientists

9 months ago

Biotech startups Upstream and CAMP4 price Friday IPOs

9 months ago

Eli Lilly inks another obesity pact, doubling down on small Swiss partner

9 months ago

Suki nabs $70M Series D to arm doctors with AI tools

9 months ago

Purespring nabs $105M to take gene therapy into the clinic as IgAN field matures

9 months ago

John Maraganore's RNAi biotech City Therapeutics debuts with $135M Series A

9 months ago

Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval

9 months ago

Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis

9 months ago

Astellas places new bet on gene therapy in $50M upfront deal with UK startup

9 months ago

Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases

9 months ago

Exclusive: Tiny startup with big vision to extend healthspan by 20 years says it discovered an ‘Atlas of Rejuvenation’

9 months ago

Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech

9 months ago

Upstream and CAMP4 target $182M, $67M IPOs

9 months ago

Biotech's third quarter was relatively bright — with a few caveats

9 months ago

First page Previous page 9 10 111213 14 15 Next page Last page